Search clinical trials for: Agent DCB

Total 188725 results

National Institute of Cardiovascular Diseases,...

Recruiting

Clinical and Angiographic Outcomes of Post-drug-coated Balloon Angioplasty in Native Coronary Lesions

Coronary Artery Disease

Bangladesh
Fundación EPIC

Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients (PARIS)

Coronary Artery Disease

Spain
DCB Research AG

Not yet recruiting

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes (TIMES)

Diabetes Mellitus, Type 1
Seoul National University Hospital

Recruiting

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study (SFRGENISTA)

Coronary Artery Disease | In-stent Restenosis

Korea, Republic of
Fu Wai Hospital, Beijing, China

Not yet recruiting

Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease

Coronary Heart Disease

China
China National Center for Cardiovascular Diseases

Recruiting

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial (STENTLESS)

De Novo Stenosis | Drug-coated Balloon | Drug-eluting Stent

China
Biotronik CRC Inc.

Recruiting

BRight Pharmacokinetic Study

Peripheral Artery Disease

Australia
B. Braun Medical International Trading Company...

Recruiting

Paclitaxel Drug-eluting Balloon Catheters in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis and Restenosis

Stroke | Intracranial Atherosclerotic Stenosis

China
Shanghai Bomaian Medical Technology Co., Ltd

Not yet recruiting

Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula

Peripheral Arterial Disease
M.A. Med Alliance S.A.

Recruiting

SELUTION 4 De Novo Small Vessel IDE Trial

Coronary Artery Disease

United States
Airiver Medical, Inc.
Libra Medical

Recruiting

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

Central Airway Obstruction

Georgia
Airiver Medical, Inc.

Recruiting

Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH)

Chronic Rhinosinusitis

Paraguay
Ain Shams University

Recruiting

Immediate and Short Term Outcomes for Using Drug Coated Balloons in Treating Coronary Bifurcation Lesions (DCB)

Stents | Ischemia; Heart

Egypt
Institute for Atherosclerosis Research, Russia

Recruiting

The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment (TEA-CART)

Myocardial Ischemia | Coronary Arteriosclerosis | Coronary Artery Bypass Grafting | Percutaneous Coronary Revascularization

Russian Federation
Henan Institute of Cardiovascular Epidemiology

Recruiting

Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD

Coronary Artery Disease

China
Yonsei University

Recruiting

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR) (GENISPIRE)

In-stent Restenosis

Korea, Republic of
GIE Medical

Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus (PATENT-E)

Esophageal Stricture

United States
GIE Medical

Recruiting

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel (PATENT-B)

Bowel; Stricture

United States
Deutsches Herzzentrum Muenchen
Abbott; EvidentIQ Germany GmbH; Institute of AI and Informatics in Medicine Technical...

Recruiting

Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5 (ISAR-DESIRE5)

Coronary Artery Disease | Restenoses, Coronary

Germany
Peking Union Medical College Hospital

Recruiting

DCB Versus Primary Selective Stenting in TASC C/D Femoropopliteal Artery Disease

Safety Issues | Efficacy, Self

China
University Hospital, Essen

Recruiting

Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

Peripheral Arterial Disease | Drug Eluting Balloon | Infrainguinal Peripheral Arterial Disease | Flow-mediated Dilation

Germany
Urotronic Inc.
Laborie Medical Technologies Inc.

Recruiting

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters (STREAM)

Urethral Stricture

United States
Zhejiang Zylox Medical Device Co., Ltd.

Not yet recruiting

Paclitaxel-Coated Balloon for the Treatment of AVF (AVF)

Arteriovenous Fistula
PETHEMA Foundation
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Recruiting

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Mature B-Cell Leukemia Burkitt Type | Burkitt Lymphoma (BL) | Unclassifiable Lymphoma Between DCBL and BL

Spain
Cardionovum GmbH
FCRE (Foundation for Cardiovascular Research and Education)

Recruiting

SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries (SIGNATURE)

Peripheral Arterial Disease | Superficial Femoral Artery Stenosis | Angiopathy, Peripheral

Germany
Lepu Medical Technology (Beijing) Co., Ltd.

Recruiting

A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease

Coronary Artery Disease

China
Fondazione Ricerca e Innovazione Cardiovascolare...

Recruiting

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels (TRANSFORM II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Netherlands, Italy, France, Bangladesh
Peking University Third Hospital

Not yet recruiting

Comparative Clinical Study of Drug-coating Balloon Strategy and Drug-eluting Stent Strategy (Kissing-DCB)

Coronary Artery Disease

China
Universitätsklinikum Hamburg-Eppendorf
BARMER; GermanVasc; MDEpiNet Verband Deutschland e.V.

Not yet recruiting

Analysis of Linked Health Insurance Claims and Clinical Registries to Determine Device Surveillance With Paclitaxel-coated Medical Devices (PacliVasc)

Outcome, Fatal | Paclitaxel Adverse Reaction
Acotec Scientific Co., Ltd
Beijing Tiantan Hospital

Recruiting

ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis

Stroke | Intracranial Atherosclerosis

China
Acotec Scientific Co., Ltd
Shanghai Tongji Hospital, Tongji University School of Medicine

Recruiting

ACOART Paclitaxel SVD:Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases

Coronary Disease

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

China
Concept Medical Inc.

Recruiting

SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease (FUTURE-BTK)

Atherosclerosis | Peripheral Artery Disease | Arterial Disease of Legs

Singapore, Korea, Republic of, Taiwan
Concept Medical Inc.

Recruiting

Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease (FUTURE-SFA)

Atherosclerosis | Peripheral Artery Disease | Arterial Disease

Singapore, Korea, Republic of, Taiwan
Acotec Scientific Co., Ltd

Recruiting

Acotec DCB Post Market Clinical Follow-up (FLOWER)

Peripheral Artery Disease

Germany
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
Beijing Hospital

Recruiting

Angioplasty With Paclitaxel-coated Balloon Only Strategy for Coronary de Novo Lesions (DCB-denovo)

Coronary Disease

China
Chung Mei Biopharma Co., Ltd

Not yet recruiting

Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Advanced Melanoma
Boston Scientific Corporation

Completed

Ranger™ and Ranger™ SL (OTW) DCB) in China

Femoropopliteal Artery Lesions

China
Spiden AG
DCB Research AG

Completed

A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults With Type-1 Diabetes Mellitus

Type 1 Diabetes Mellitus | Type 1 Diabetes Mellitus With Hypoglycemia | Type 1 Diabetes Mellitus With Hyperglycemia

Switzerland
Biotronik CRC Inc.
Biotronik AG

Completed

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Genoss Co., Ltd.

Completed

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis

Coronary Artery Disease
Genoss Co., Ltd.

Completed

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

Coronary Artery Disease

Korea, Republic of
Rabih A. Chaer

Completed

Evaluation of Paclitaxel in Patients With CLI and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty

Ischemia

United States
Boston Scientific Corporation

Active, not recruiting

An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients

Chinese Patients Treated With Agent DCB

Taiwan, Hong Kong, Singapore
Terumo Europe N.V.

Completed

Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter. (KANSHAS-1)

Peripheral Artery Disease | Femoropopliteal Occlusive Disease

Belgium, Germany
SurModics, Inc.

Active, not recruiting

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)

Peripheral Arterial Disease | Peripheral Vascular Disease | Femoropopliteal Artery Occlusion | Artery Disease, Peripheral

New Zealand, United States, Belgium, Latvia, Germany, Australia, Austria, Czechia, Italy
Boston Scientific Corporation

Active, not recruiting

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) (AGENT IDE)

In-Stent Restenosis

United States
Genoss Co., Ltd.

Active, not recruiting

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Chinese Patients With Coronary ISR

Coronary Artery Disease

China
Medtronic Endovascular

Active, not recruiting

IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA

Peripheral Arterial Disease | Critical Limb Ischemia

Switzerland, Belgium, France, Greece, Italy

Search clinical trials for: Agent DCB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations